Investor Relations

Key Management Personnel

Dato' Zulkifli Jafar

Managing Director
Age : 53
Gender : Male
Nationality : Malaysian
Date of Appointment to Present Position :
• 1 September 2024

Working Experience
Dato’ Zulkifli’s career began as a legal counsel at Panglima Aces Sdn. Bhd. in 1997. Rapidly ascending the ranks, he distinguished himself as an advocate and solicitor at Messrs Raslan Loong within the same year and by 2002, Dato’ Zulkifli became a partner at Messrs Rashid Zulkifli. Beyond his legal practice, Dato’ Zulkifli serves as a director and major shareholder of MMA Resources Sdn. Bhd., an oil & gas company.

In addition to his corporate responsibilities, Dato’ Zulkifli is actively engaged in shaping the landscape of development and governance. Currently, he holds the positions of Chairman and Director at Era Universe Development Sdn. Bhd., a development company.

Dato’ Zulkifli had served as the Legal Advisor for Johor State Government Linked Companies (GLC). His diverse portfolio included directorships in esteemed organisations such as the Cooperative Commission of Malaysia, the regulator body of cooperatives in the country; Board of Trustee of the Foundation of Research and Transformation, an independent think tank research body of the Prime Minister’s Office; and Songa Offshore Malaysia Sdn. Bhd.

Internationally, Dato’ Zulkifli was a director and management member of the Chartridge Conference Centre (UK) Limited, overseeing the operations of four hotels and conference centres in the United Kingdom.

In 2020, Dato’ Zulkifli assumed the position of Chairman at ldaman Pharma Manufacturing Sdn. Bhd., a subsidiary of Pharmaniaga Berhad (Pharmaniaga) and subsequently, appointed as the Group Executive Director of Pharmaniaga in March 2022. In February 2023, he was redesignated as Deputy Chief Executive Officer of Pharmaniaga.

In January 2023, Dato’ Zulkifli was appointed as a board member of University Sains Islam Malaysia (USIM) and in June 2023, he was appointed to be the Chairman of USIM Tijarah Holdings Sdn. Bhd., the holding company of USIM. He was also appointed as the Chairman of the Advisory Panel (Faculty of Sharia and Law) and the Investment Committee.

On 1 March 2024, Dato’ Zulkifli was appointed as the Executive Director of Pharmaniaga, taking over the role and functions of the Executive Committee which was dissolved, and subsequently, he was redesignated as Managing Director on 1 September 2024.

Qualification(s):
• Master of Business Administration, MAHSA University
• Certified Patent Agent
• Advocate and Solicitor of the High Court of Malaya
• Admission to Malaysian Bar in 1996
• Bachelor of Laws (Honours), Universiti Islam Antarabangsa Malaysia

Directorship in other public listed companies:
• PT Millennium Pharmacon International Tbk

Directorship in public companies:
• None

Any family relationship with any director and/major shareholder of the Company:
• None

Any conflict of interests with the Company:
• None.

Other than traffic offences, any convictions for offences within the past 5 years and other particulars of any public sanction or penalty imposed by the relevant regulatory bodies during the financial year, if any:
• None

Ahmad Shahredzuan Mohd Shariff

Chief Operating Officer
Age : 43
Gender : Male
Nationality : Malaysian
Date of Appointment to Present Position :
• 1 October 2024 (Chief Operating Officer)

Working Experience
Ahmad Shahredzuan began his career at Permodalan Nasional Berhad in 2006. His last position was Senior Manager at the Office of President and Group Chief Executive. Subsequently, he joined McKinsey & Company in 2015 as an Implementation Consultant, where he was involved in the strategy and execution of numerous projects.

In 2019, he expanded his horizon by joining Boustead Holdings Berhad (Boustead) as Senior General Manager. He then rose in the ranks within the Boustead Group to Chief Transformation Officer in May 2020. In March 2021, Ahmad Shahredzuan was appointed as Chief Reinvention and Strategy Officer of Boustead and later redesignated to Group Chief Reinvention and Strategy Officer effective March 2023.

He holds a Bachelor of Economics from the University of Warwick, United Kingdom and obtained his Graduate Diploma of Applied Finance from Kaplan Higher Education in Australia. On 22 February 2023, he was appointed as Non-Independent Non-Executive Director of Pharmaniaga and later appointed as Chief Operating Officer effective 1 October 2024.

Qualification(s):
• Graduate Diploma of Applied Finance, Kaplan Higher Education, Australia
• Bachelor of Economics, University of Warwick, United Kingdom

Any directorship in public companies and public listed companies:
• None

Directorship in public companies:
• None.

Any family relationship with any director and/major shareholder of the Company:
• None

Any conflict of interests with the Company:
• None.

Other than traffic offences, any convictions for offences within the past 5 years and other particulars of any public sanction or penalty imposed by the relevant regulatory bodies during the financial year, if any:
• None

Norai’ni Mohamed Ali

Group Chief Financial Officer
Age : 59
Gender : Female
Nationality : Malaysian
Date of Appointment to Present Position : 1 June 2012

Working Experience
Norai’ni is Pharmaniaga’s Chief Financial Officer and brings 34 years of vast working experience in accounting and finance.

Her professional career with the Company extends nearly 25 years. She is an accomplished talent who oversees all financial matters, including acquisition of strategic business, treasury, taxation, risk management strategies and formulation of financial policies and tax planning of Pharmaniaga.

Norai’ni joined the Company in 2001 as a Deputy General Manager of Finance. Subsequently, she was appointed as CFO in 2012 and presently sits on the Boards of Pharmaniaga's subsidiaries.

Prior to joining the Company, Norai’ni was attached to Opus Group Berhad, a subsidiary of UEM Group Berhad, for eight years. A Chartered Accountant and a fellow member of Association of Chartered Certified Accountant (FCCA), Norai’ni is also a member of the Malaysian Institute of Accountant (MIA) and the ASEAN Chartered Professional Accountants (ASEAN CPA).

Qualification(s):
• Fellow, Association of Chartered Certified Accountants (FCCA)
• Chartered Accountant, Malaysia Institute of Accountants (MIA)
• ASEAN Chartered Professional Accountants (ASEAN CPA)
• Bachelor of Arts (Honours), Accounting and Finance, Liverpool John Moores University, United Kingdom

Any directorship in public companies and public listed companies:
• None

Directorship in public companies:
• None

Any family relationship with any director and/ major shareholder of the Company:
• None

Any conflict of interests with the Company:
• None

Other than traffic offences, any convictions for offences within the past 5 years and other particulars of any public sanction or penalty imposed by the relevant regulatory bodies during the financial year, if any:
• None

Dr. Badarulhisam Abdul Rahman

Chief Scientific Officer
Age : 58
Gender : Male
Nationality : Malaysian
Date of Appointment to Present Position : 1 January 2023

Working Experience
As the Chief Scientific Officer at Pharmaniaga, Dr. Badarulhisam spearheads product development and regulatory strategies for the Company, which include product ideation, development, trial, registration, and product life cycle management. He has extensive experience in pharmaceutical and biopharmaceutical manufacturing plant design, construction, equipment and facility qualification & process validation and the operation of these plants for the manufacturing of various therapeutic segments and dosage forms including vaccine.

Dr. Badarulhisam was instrumental in establishing Pharmaniaga’s Group-wide sustainability programme, which he headed from 2017 to 2022. He is a qualified Biochemical Engineer with expertise in Biochemical Engineering and Biotechnology.

He completed his Advanced Diploma and Master of Science at University College of London in the United Kingdom and subsequently, obtained his PhD from Johns Hopkins University in the United States of America.

Dr. Badarulhisam began his career as a lecturer at the Department of Bioprocess Engineering, Universiti Teknologi Malaysia, where he is still academically active. He then served as an Adjunct Professor at the Chemical Engineering Department of Universiti Putra Malaysia.

Amongst his other accomplishments include his appointment as Board of Academic Advisory of the Faculty of Engineering at Universiti Kebangsaan Malaysia and several other universities. He has also served as an industrial advisor to several Bioprocess Engineering Programmes of major universities in Malaysia and co-supervises Master’s and PhD students in various aspects of Biopharmaceutical Plant Design, Biologics Drug Development and Process Optimisations.

Qualification(s):
• PhD in Biotechnology, Johns Hopkins University, USA
• MSc in Biochemical Engineering, University College London, United Kingdom
• Advanced Diploma in Biochemical Engineering, University College London, United Kingdom

Any directorship in public companies and public listed companies:
• None

Directorship in public companies:
• None.

Any family relationship with any director and/major shareholder of the Company:
• None

Any conflict of interests with the Company:
• None.

Other than traffic offences, any convictions for offences within the past 5 years and other particulars of any public sanction or penalty imposed by the relevant regulatory bodies during the financial year, if any:
• None

Wan Intan Idura Wan Ismail

Chief Governance Officer
Age : 46
Gender : Female
Nationality : Malaysian
Date of Appointment to Present Position : 1 August 2024

Working Experience
Wan Intan Idura joined Pharmaniaga in 2010 as Assistant Manager in the Legal Department and was promoted to Head of the Legal Department in 2012.

Her dedication and expertise led to further career advancements within the Company, as she expanded her skills and knowledge in corporate governance and legal management.

In 2017, she was promoted to Deputy Director of the Corporate Governance Division and subsequently appointed as Director on 1 July 2021. She has also served as the Company Secretary of Pharmaniaga Berhad since 19 November 2019, overseeing all legal and secretarial functions of the Company.

On 1 August 2024, Wan Intan Idura was appointed as Chief Governance Officer, a role in which she leads the Legal, Secretarial, Risk Management, Sustainability, Compliance, and Corporate System functions of Pharmaniaga.

Admitted to the Malaysian Bar in 2006, Wan Intan Idura brings over 19 years of experience as an in-house legal counsel. Her expertise spans both local and international dealings across industries such as pharmaceutical, information technology solutions, manufacturing and automotive.

Qualification(s):
• Licensed Company Secretary (LS 0010668)
• Admission to Malaysian Bar in 2006
• Bachelor of Laws (Honours), Universiti Teknologi MARA

Any directorship in public companies and public listed companies:
• None

Directorship in public companies:
• None

Any family relationship with any director and/ major shareholder of the Company:
• None

Any conflict of interests with the Company:
• None

Other than traffic offences, any convictions for offences within the past 5 years and other particulars of any public sanction or penalty imposed by the relevant regulatory bodies during the financial year, if any:
• None

Erick Arjunan Kereshanan

Chief Commercial Officer
Age : 53
Gender : Male
Nationality : Malaysian
Date of Appointment to Present Position :
• 2 September 2025

Working Experience
Erick brings with him over 20 years of extensive experience in the pharmaceutical and healthcare industries.

He began his career at Bristol Myers Squibb, where he gained foundational experience in pharmaceutical operations and commercial strategy. His early exposure to global healthcare practices laid the groundwork for his future leadership roles. He later advanced to become Director of Marketing and Sales at Sanofi a position in which he played a pivotal role in driving regional sales performance, expanding market access especially the insulin and Genzyme portfolios, driving new product launches and strengthening market shares across different portfolios and markets.

Over the years, Erick has held senior positions in various reputable organisations such as Novo Nordisk and Merck, consistently delivering results through strategic planning, commercial excellence, business transformation and cross-functional collaboration. His ability to navigate complex market environments and lead high-performing teams has contributed significantly to the success of numerous blockbuster product launches and regional growth initiatives.

Erick holds a Master of Business Administration from Charles Sturt University and a Bachelor of Pharmacy from the University of Manchester.

Qualification(s):
• Master of Business Administration, Charles Sturt University, Australia
• Bachelor of Pharmacy, University of Manchester, England

Any directorship in public companies and public listed companies:
• None

Directorship in public companies:
• None.

Any family relationship with any director and/major shareholder of the Company:
• None

Any conflict of interests with the Company:
• None.

Other than traffic offences, any convictions for offences within the past 5 years and other particulars of any public sanction or penalty imposed by the relevant regulatory bodies during the financial year, if any:
• None

Mohd Izwan Ishak

Head of Manufacturing
Age : 47
Gender : Male
Nationality : Malaysian
Date of Appointment to Present Position : 1 February 2024

Working Experience
MMohd Izwan started his career at Pharmaniaga as Head of Production Section and progressed to General Manager of Pharmaniaga Manufacturing Berhad, before being appointed as the Head of Manufacturing Operations of the Manufacturing Division effective 1 August 2024.

With over 23 years of experience under his belt in the pharmaceutical industry, he presently leads the four plants located throughout Malaysia. Apart from overseeing superior supply performance and continuous improvement activities of each plant, he led the capacity balancing improvement including the readiness of manufacturing facilities, utilities, equipment and developed organisational capability.

Prior to joining Pharmaniaga, Mohd Izwan was a New Product Development Manager at GlaxoSmithKline (M) Sdn. Bhd. with 9 years of experience in various positions within the company.

Mohd Izwan graduated with a Bachelor of Accounting (Honours) from Universiti Putra Malaysia. He is an active member of various pharmaceutical societies, both locally and internationally, such as the International Society for Pharmaceutical Engineering (ISPE) and a member of the Malaysian Organisation of Pharmaceutical Industries (MOPI).

Qualification(s):
• Bachelor of Accounting (Honours), Universiti Putra Malaysia

Any directorship in public companies and public listed companies:
• None

Directorship in public companies:
• None

Any family relationship with any director and/ major shareholder of the Company:
• None

Any conflict of interests with the Company:
• None

Other than traffic offences, any convictions for offences within the past 5 years and other particulars of any public sanction or penalty imposed by the relevant regulatory bodies during the financial year, if any:
• None

Hairulrizal Samuri

Head of Logistics and Distribution
Age: 48
Gender: Male
Nationality: Malaysian
Date of Appoinment to present position: 21 April 2025

Working Experience
Hairul has over 25 years of experience in supply chain management, procurement, logistics and distribution, with a proven track record in the semiconductors, oil & gas, construction, chemical and pharmaceutical sectors, across Malaysia and internationally. He began his career as an Assistant Manager, Production Planning and Logistics at Ericsson in 1999, where he gained experience in inventory management, logistics, and production operation.

He progressed to lead global logistics operations at Emerson Process Management and later drove distribution and supply chain efficiency as ASEAN Regional Logistics Head, at Bluescope Steel Asia in 2011. His ability to streamline operational excellence further expanded when he became the General Manager of Supply Chain at Cement Industries of Malaysia Berhad (CIMA) from 2013 to 2019.

He moved to Vietnam till 2023 where he attached to BMT Logistics, responsible for 3PL operations before assumed the role of Global Director at Twinstar Home, overseeing logistics and supply chain operations across ASEAN, China and US regions. Before joining Pharmaniaga in April 2025, Hairul was the Director of Supply Chain at Omya Malaysia, where he managed the country’s supply chain operations for pharmaceutical and chemical products.

His strengths in strategic planning, operational excellence, supply chains optimization, and ability to lead diverse teams to achieve business growth make him a key player in any supply chain operation.

Qualification(s):
• Master of Business Administration (Strategic Management), Universiti Teknologi Malaysia
• Bachelor of Business Administration (Honours) in Human Resources, Universiti Teknologi MARA
• Diploma in Banking, Universiti Teknologi MARA

Any directorship in public companies and public listed companies:
None

Any family relationship with any director and/major shareholder of the Company:
None

Any conflict of interests with the Company:
None

Other than traffic offences, any convictions for the past 5 years and other particulars of any public sanction or penalty imposed by the None relevant regulatory bodies during the financial year, if any:
None

Zulhazri Razali

Head of Market Expansion Services
Age : 59
Gender : Male
Nationality : Malaysian
Date of Appointment to Present Position : 1 December 2014

Working Experience
Zulhazri joined Pharmaniaga in 1994 as an Assistant Manager of Customer Care, marking the beginning of a remarkable journey within the company. Over the years, he has broadened his expertise across various disciplines, including warehouse management, supply chain, international business, sales and marketing, finance, and business strategy.

In 2014, he was promoted to Commercial Director, where he took charge of the Sales & Marketing Division and played a pivotal role in identifying strategic business opportunities for the Group’s healthcare portfolios within both the private and Government sectors in Malaysia.

On 1 December 2024, Zulhazri was redesignated as the Head of Government Business Unit, subsequently renamed to Market Expansion Services, tasked with overseeing all Government-related business functions.

Qualification(s):
• Master of Business Administration from University of Manchester, United Kingdom
• Bachelor of Science (Honours), Pharmacy from University of Manchester, United Kingdom

Any directorship in public companies and public listed companies:
• None

Directorship in public companies:
• None

Any family relationship with any director and/ major shareholder of the Company:
• None

Any conflict of interests with the Company:
• None

Other than traffic offences, any convictions for offences within the past 5 years and other particulars of any public sanction or penalty imposed by the relevant regulatory bodies during the financial year, if any:
• None

Dr Imam Fathorrahman

Head of Indonesia Operations
Age : 61
Gender : Male
Nationality : Indonesian
Date of Appointment to Present Position : 2 Janaury 2026

Working Experience
Dr. Imam brings a wealth of experience and expertise to the company, supported by a strong educational foundation and decades of professional experience in the pharmaceutical industry.

With a broad expertise spanning marketing and sales strategy, business strategy, retail, pharmaceutical, business development, and healthcare, he brings a multifaceted skill set to the boardroom, ready to drive strategic initiatives and propel organisational success to new heights.

After earning his Bachelor of Pharmacy degree in 1989, Dr. Imam began his career journey in the pharmaceutical field. Driven by a passion for innovation and strategic foresight, he pursued a Master of Strategic Management to equip himself with the knowledge and skills needed to navigate the complexities of the modern business landscape. Along with the development of science and the challenges of the pharmaceutical industry in the future, Dr. Imam has completed his doctoral programme in Pharmaceutical Sciences at Airlangga University in December 2024.

In 2011 to 2019, he was appointed as President Director of PT Kimia Farma Apotek. Furthermore, Dr. Imam was given a new assignment as Director of Business Development at PT Kimia Farma Tbk in 2019 to strengthen PT Kimia Farma Tbk’s position as a holding company to adapt to new challenges and provide invaluable insights in establishing strategic partnerships and driving sustainable growth initiatives.

Recognised for his outstanding contributions, Dr. Imam held the position of Marketing & Commercial Director from 2021 to 2022, further highlighting his expertise in creating robust marketing and sales strategies to capture the ever-evolving market dynamics.

Dr Imam, who previously served as an Independent Non-Executive Director, was redesignated as Head of Indonesia Operations with effect from 2 January 2026.

Qualification(s):
• Doctor of Pharmaceutical Sciences, Airlangga University, Indonesia
• Master of Strategic Management, PPM School of Management, Indonesia
• Bachelor of Pharmacy, Airlangga University, Indonesia

Any directorship in public companies and public listed companies:
• None

Directorship in public companies:
• None

Any family relationship with any director and/ major shareholder of the Company:
• None

Any conflict of interests with the Company:
• None

Other than traffic offences, any convictions for offences within the past 5 years and other particulars of any public sanction or penalty imposed by the relevant regulatory bodies during the financial year, if any:
• None

Raja Ahmad Hidzir Raja Muhamad

Head of Human Capital Management & Administration
Age : 54
Gender : Male
Nationality : Malaysian
Date of Appointment to Present Position : 1 April 2026

Working Experience
Raja Ahmad Hidzir brings over 30 years of extensive experience in human capital management, organisational development, and corporate administration across both public-listed companies and multinational organisations.

Prior to joining Pharmaniaga, he served as Group Chief People Officer at Pos Malaysia Berhad, where he led enterprise-wide human capital strategies, organisational transformation initiatives, and employee engagement programmes across the Group and its subsidiaries.

Previously, he was Head of Human Resources & Administration at Pengurusan Air Selangor Sdn Bhd, part of the Transformation team involved in the restructuring of the water industry in Selangor, KL, and Putrajaya. In this capacity, he led end-to-end HR, administration, security, and health, safety & environment functions, while supporting corporate governance, digitalisation initiatives, and large-scale organisational transformation initiatives.

His earlier career includes senior leadership roles at Kumpulan Perangsang Selangor Berhad as Group General Manager, Human Resources, as well as key positions in Malayan Banking Berhad, Adidas (Malaysia) Sdn Bhd, Deloitte Touche Tohmatsu and Edaran Otomobil Nasional Berhad.

He holds a Bachelor of Management (Honours), majoring in Finance and Accounting, from Universiti Sains Malaysia.

Qualification(s):
• Bachelor of Management (Hons), majoring in Finance & Accounting, and a minor in Economics, Universiti Sains Malaysia

Any directorship in public companies and public listed companies:
• None

Directorship in public companies:
• None

Any family relationship with any director and/ major shareholder of the Company:
• None

Any conflict of interests with the Company:
• None

Other than traffic offences, any convictions for offences within the past 5 years and other particulars of any public sanction or penalty imposed by the relevant regulatory bodies during the financial year, if any:
• None

Khairul Nizar Mohd Arip

Head of Information Technology & Digitalisation
Age : 47
Gender : Male
Nationality : Malaysian
Date of Appointment to Present Position : 1 August 2025

Working Experience
Khairul Nizar joined Pharmaniaga in August 2025 as Head of Information Technology & Digitalisation, where he provides strategic leadership for the Group’s technology agenda. He is responsible for shaping and executing the Group’s IT and digitalisation strategy, strengthening cybersecurity and governance frameworks, and overseeing enterprise technology platforms to enable sustainable growth, operational resilience, and long-term value creation.

He brings over 22 years of senior technology leadership experience across healthcare, reinsurance, and technology services, with a strong track record in driving enterprise-wide transformation initiatives. Khairul also possesses significant global exposure, having worked with leading multinational corporations across diverse industries, including Dell and Hewlett- Packard (Global Technology and IT Services), Shell (Energy), and Standard Chartered Bank (International Banking and Financial Services), where he supported large-scale technology initiatives within a highly regulated environment governed by Bank Negara Malaysia.

Prior to joining Pharmaniaga, Khairul served as Chief Technology Officer of WISEYES Solution Sdn. Bhd., where he led the development and management of PERKESO core applications in compliance with statutory requirements under the Ministry of Human Resources. He also held the role of Chief of Information Technology at Labuan Reinsurance (L) Ltd.

He previously served as Head of Information Technology at PUSPAKOM Sdn. Bhd., a concession-based business operating under regulatory oversight of the Ministry of Transport, where he was responsible for nationwide IT operations, enterprise systems, and data centre management.

In 2014, Khairul obtained a Master in Management from Asia Metropolitan University after being selected among the Top 20 participants of the DRB-HICOM Top Talent Programme, a senior leadership development initiative designed to groom high-potential executives.

Qualification(s):
• Master in Management, Asia Metropolitan University, Malaysia
• Bachelor of Science (Honours), Computer Science, Universiti Teknologi MARA
• Diploma in Computer Science, Universiti Teknologi MARA

Any directorship in public companies and public listed companies:
• None

Directorship in public companies:
• None

Any family relationship with any director and/ major shareholder of the Company:
• None

Any conflict of interests with the Company:
• None

Other than traffic offences, any convictions for offences within the past 5 years and other particulars of any public sanction or penalty imposed by the relevant regulatory bodies during the financial year, if any:
• None